AU9125991A - Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides - Google Patents
Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosidesInfo
- Publication number
- AU9125991A AU9125991A AU91259/91A AU9125991A AU9125991A AU 9125991 A AU9125991 A AU 9125991A AU 91259/91 A AU91259/91 A AU 91259/91A AU 9125991 A AU9125991 A AU 9125991A AU 9125991 A AU9125991 A AU 9125991A
- Authority
- AU
- Australia
- Prior art keywords
- enantiomerically pure
- pure beta
- oxathiolane nucleosides
- oxathiolane
- nucleosides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US622762 | 1990-12-05 | ||
US07/622,762 US5179104A (en) | 1990-12-05 | 1990-12-05 | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US69919791A | 1991-05-13 | 1991-05-13 | |
US699197 | 1991-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9125991A true AU9125991A (en) | 1992-07-08 |
Family
ID=27089275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU91259/91A Abandoned AU9125991A (en) | 1990-12-05 | 1991-12-05 | Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU9125991A (en) |
WO (1) | WO1992010496A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6175008B1 (en) | 1988-04-11 | 2001-01-16 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
HU226137B1 (en) * | 1989-02-08 | 2008-05-28 | Shire Canada Inc | Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5728575A (en) | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
GB9311709D0 (en) * | 1993-06-07 | 1993-07-21 | Iaf Biochem Int | Stereoselective synthesis of nucleoside analogues using bicycle intermediate |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
JPH09504785A (en) | 1993-09-10 | 1997-05-13 | エモリー、ユニバーシティー | Nucleosides with anti-hepatitis B virus activity |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
CA2203262A1 (en) * | 1994-10-22 | 1996-05-02 | Byeong Seon Jeong | Nucleoside derivatives and process for preparing thereof |
US5703058A (en) | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
GB9503850D0 (en) * | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
AU722214B2 (en) | 1995-06-07 | 2000-07-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis B virus activity |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
EP0970078B1 (en) | 1997-03-19 | 2004-05-19 | Emory University | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
CA2714085C (en) * | 1998-08-12 | 2013-02-05 | Emory University | Method of manufacture of 1,3-oxathiolane nucleosides |
JP2002533470A (en) | 1998-12-23 | 2002-10-08 | シャイアー・バイオケム・インコーポレイテッド | Antiviral nucleoside analogues |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
CN102234269B (en) * | 2010-04-29 | 2015-09-16 | 重庆医药工业研究院有限责任公司 | The industrialized process for preparing of lamivudine |
CN102796088B (en) * | 2012-05-21 | 2015-06-10 | 湖南千金湘江药业股份有限公司 | Method for preparing lamivudine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US5041449A (en) * | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
-
1991
- 1991-12-05 WO PCT/US1991/009123 patent/WO1992010496A1/en active Application Filing
- 1991-12-05 AU AU91259/91A patent/AU9125991A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1992010496A1 (en) | 1992-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9125991A (en) | Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides | |
HK1043940A1 (en) | 1,3-Oxathiolane nucleoside analoques. | |
EP0456063A3 (en) | 1-h-3-aryl-pyrrolidin-2,4-dion-derivatives | |
AU7818891A (en) | Sdh rejustification | |
AU4920190A (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
AU639126B2 (en) | Oxorapamycin | |
AU8069291A (en) | Substituted 1-h-pyrrolo(2,3-b)pyridine-3-carboxamides | |
GB9116601D0 (en) | 1,3-oxathiolane nucleoside analogues | |
AU2992689A (en) | 2',3'-dideoxy-2',2'-difluoronucleosides | |
AU1704588A (en) | Amino-9,10-secosteroids | |
AU7855191A (en) | 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents | |
AU8827191A (en) | Working gondola | |
AU7378991A (en) | Exercise bike | |
AU8518791A (en) | Bicycle frame | |
AU8420191A (en) | Headwear | |
AU8612491A (en) | Antiviral compounds | |
AU8764191A (en) | Ibuprofen-antihistamine combinations | |
EP0710107A4 (en) | N,n,n-trimethylsphingosine derivatives | |
AU7124691A (en) | Benzofurans | |
AU4511489A (en) | 14alpha,17alpha-ethano-estratrienes | |
AU566917B2 (en) | 5-oxo-2,4-dichloro-4-substituted pentanenitriles | |
AU7507591A (en) | Antiviral compounds | |
AU3384793A (en) | 2-acetyl-3-keto-4,5-dihydrothiphene compounds | |
AU8516291A (en) | Instant photograph-postcard | |
AU7112891A (en) | Therapeutic nucleosides |